<?xml version='1.0'?>
<!DOCTYPE art SYSTEM 'http://www.biomedcentral.com/xml/article.dtd'>
<art>
   <ui>ar1564</ui>
   <ji>ARJ</ji>
   <fm>
      <dochead>Poster presentation</dochead>
      <bibl>
         <title>
            <p>A role for IL-7 in regulating CD4<sup>+</sup>CD25<sup>high </sup>regulatory T cells</p>
         </title>
         <aug>
            <au id="A1">
               <snm>Lawson</snm>
               <fnm>CA</fnm>
               <insr iid="I1"/>
               <insr iid="I2"/>
            </au>
            <au id="A2">
               <snm>Brown</snm>
               <fnm>AK</fnm>
               <insr iid="I1"/>
            </au>
            <au id="A3">
               <snm>Field</snm>
               <fnm>SL</fnm>
               <insr iid="I2"/>
            </au>
            <au id="A4">
               <snm>Burgoyne</snm>
               <fnm>C</fnm>
               <insr iid="I2"/>
            </au>
            <au id="A5">
               <snm>Emery</snm>
               <fnm>P</fnm>
               <insr iid="I1"/>
            </au>
            <au id="A6">
               <snm>Isaacs</snm>
               <fnm>JD</fnm>
               <insr iid="I3"/>
            </au>
            <au id="A7">
               <snm>Ponchel</snm>
               <fnm>F</fnm>
               <insr iid="I1"/>
               <insr iid="I2"/>
            </au>
         </aug>
         <insg>
            <ins id="I1">
               <p>Department of Rheumatology, University of Leeds, UK</p>
            </ins>
            <ins id="I2">
               <p>Molecular Medicine Unit, University of Leeds, UK</p>
            </ins>
            <ins id="I3">
               <p>Department of Rheumatology, University of Newcastle, UK</p>
            </ins>
         </insg>
         <source>Arthritis Research &amp; Therapy</source>
         <supplement>
            <title>
               <p>25<sup>th</sup> European Workshop for Rheumatology Research</p>
            </title>
            <sponsor>
               <note>The organizer would like to thank the following companies who have generously supported the meeting: Abbott Immunology (Main sponsor), Bristol-Myers Squibb, Schering-Plough, Wyeth, AstraZeneca, MSD, Amgen</note>
            </sponsor>
            <note>Meeting abstracts</note>
         </supplement>
         <conference>
            <title>
               <p>25<sup>th</sup> European Workshop for Rheumatology Research</p>
            </title>
            <location>Glasgow, UK</location>
            <date-range>24-27 February 2005</date-range>
         </conference>
         <issn>1478-6354</issn>
         <pubdate>2005</pubdate>
         <volume>7</volume>
         <issue>Suppl 1</issue>
         <fpage>P43</fpage>
         <xrefbib>
            <pubid idtype="doi">10.1186/ar1564</pubid>
         </xrefbib>
      </bibl>
      <history>
         <rec>
            <date>
               <day>11</day>
               <month>1</month>
               <year>2005</year>
            </date>
         </rec>
         <pub>
            <date>
               <day>17</day>
               <month>2</month>
               <year>2005</year>
            </date>
         </pub>
      </history>
      <cpyrt>
         <year>2005</year>
         <collab>BioMed Central Ltd</collab>
      </cpyrt>
   </fm>
   <bdy>
      <sec>
         <st>
            <p>Background</p>
         </st>
         <p>Despite the accumulation of evidence that CD4<sup>+</sup>CD25<sup>high </sup>regulatory T cells play an important role in the prevention of autoimmune disease, little is known about how they are regulated <it>in vivo</it>. There are thought to be at least two mechanisms for the generation of regulatory T cells: naturally occurring CD4<sup>+</sup>CD25<sup>high </sup>regulatory T cells derive from the thymus, and peripherally-induced regulatory cells arise under tolerogenic conditions. Recently, cytokine activation requirements for CD4<sup>+</sup>CD25<sup>high </sup>regulatory T-cell function were associated with IL-7, as well as IL-2 and IL-4. We examined a cohort of patients with rheumatoid arthritis whose disease was well controlled, and where we had previously shown that heterogeneous circulating levels of IL-7 positively correlated with thymic activity, to investigate the role of IL-7 on the function of CD4<sup>+</sup>CD25<sup>high </sup>T cells.</p>
      </sec>
      <sec>
         <st>
            <p>Methods</p>
         </st>
         <p>Peripheral blood samples were taken from patients with rheumatoid arthritis whose disease was well controlled. Serum IL-7 levels were measured by ELISA. Quantification of the CD4<sup>+</sup>CD25<sup>high </sup>T-cell subset was performed using flow cytometry. Thymic activity was evaluated by real-time PCR quantification of T-cell receptor excision circles in CD4<sup>+ </sup>T cells. Thymidine incorporation assays were used to assess the response of CD4<sup>+</sup>CD25<sup>high </sup>T cells to IL-7 stimulation, and also their ability to suppress the proliferation of CD4<sup>+</sup>CD25<sup>- </sup>T cells in response to phytohaemagglutinin in co-culture.</p>
      </sec>
      <sec>
         <st>
            <p>Results</p>
         </st>
         <p>Circulating levels of IL-7 positively correlated with the frequency of circulating CD4<sup>+</sup>CD25<sup>high </sup>T cells (<it>n </it>= 47, <it>R </it>= 0.647, <it>P </it>&lt; 0.0001). This appeared to result from an increased production of these cells by the thymus. High levels of circulating IL-7 <it>in vivo </it>were associated with increased suppressor functions of CD4<sup>+</sup>CD25<sup>high </sup>T cells <it>in vitro </it>(<it>n </it>= 5, mean 79% suppression by cells from patients with high IL-7 levels, and 39% suppression by cells from patients with low IL-7 levels). In patients with low circulating IL-7 levels, adding exogenous IL-7 to co-cultures appeared to increase suppression.</p>
      </sec>
      <sec>
         <st>
            <p>Conclusions</p>
         </st>
         <p>Our data suggest that IL-7 has a role in regulating CD4<sup>+</sup>CD25<sup>high </sup>T-cell number and function. Circulating IL-7 levels are low in active rheumatoid arthritis, and this may be a contributory factor to the reduced size and suppressor function of the CD4<sup>+</sup>CD25<sup>high </sup>regulatory T-cell population in this disease.</p>
      </sec>
   </bdy>
</art>
